13-23320615-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000231.3(SGCG):c.579-22G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 12 hom., cov: 0)
Exomes 𝑓: 0.063 ( 1291 hom. )
Failed GnomAD Quality Control
Consequence
SGCG
NM_000231.3 intron
NM_000231.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.375
Publications
3 publications found
Genes affected
SGCG (HGNC:10809): (sarcoglycan gamma) This gene encodes gamma-sarcoglycan, one of several sarcolemmal transmembrane glycoproteins that interact with dystrophin. The dystrophin-glycoprotein complex (DGC) spans the sarcolemma and is comprised of dystrophin, syntrophin, alpha- and beta-dystroglycans and sarcoglycans. The DGC provides a structural link between the subsarcolemmal cytoskeleton and the extracellular matrix of muscle cells. Defects in the encoded protein can lead to early onset autosomal recessive muscular dystrophy, in particular limb-girdle muscular dystrophy, type 2C (LGMD2C). [provided by RefSeq, Oct 2008]
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
- Charlevoix-Saguenay spastic ataxiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 13-23320615-G-T is Benign according to our data. Variant chr13-23320615-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 1291 AR gene
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000231.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SGCG | NM_000231.3 | MANE Select | c.579-22G>T | intron | N/A | NP_000222.2 | |||
| SGCG | NM_001378244.1 | c.633-22G>T | intron | N/A | NP_001365173.1 | ||||
| SGCG | NM_001378245.1 | c.579-22G>T | intron | N/A | NP_001365174.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SGCG | ENST00000218867.4 | TSL:1 MANE Select | c.579-22G>T | intron | N/A | ENSP00000218867.3 | |||
| SACS | ENST00000682775.1 | c.2186-8500C>A | intron | N/A | ENSP00000508399.1 | ||||
| SACS | ENST00000683210.1 | c.2186-31372C>A | intron | N/A | ENSP00000506739.1 |
Frequencies
GnomAD3 genomes AF: 0.0220 AC: 1041AN: 47416Hom.: 10 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
1041
AN:
47416
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.136 AC: 13558AN: 99330 AF XY: 0.143 show subpopulations
GnomAD2 exomes
AF:
AC:
13558
AN:
99330
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0628 AC: 40498AN: 645318Hom.: 1291 Cov.: 17 AF XY: 0.0642 AC XY: 20422AN XY: 318308 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
40498
AN:
645318
Hom.:
Cov.:
17
AF XY:
AC XY:
20422
AN XY:
318308
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
543
AN:
12884
American (AMR)
AF:
AC:
1783
AN:
15126
Ashkenazi Jewish (ASJ)
AF:
AC:
1476
AN:
9862
East Asian (EAS)
AF:
AC:
969
AN:
14144
South Asian (SAS)
AF:
AC:
4018
AN:
33566
European-Finnish (FIN)
AF:
AC:
2467
AN:
22196
Middle Eastern (MID)
AF:
AC:
181
AN:
2050
European-Non Finnish (NFE)
AF:
AC:
27427
AN:
509470
Other (OTH)
AF:
AC:
1634
AN:
26020
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.354
Heterozygous variant carriers
0
1988
3976
5963
7951
9939
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1070
2140
3210
4280
5350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0221 AC: 1048AN: 47470Hom.: 12 Cov.: 0 AF XY: 0.0232 AC XY: 542AN XY: 23386 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1048
AN:
47470
Hom.:
Cov.:
0
AF XY:
AC XY:
542
AN XY:
23386
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
316
AN:
11516
American (AMR)
AF:
AC:
86
AN:
4602
Ashkenazi Jewish (ASJ)
AF:
AC:
18
AN:
832
East Asian (EAS)
AF:
AC:
21
AN:
1472
South Asian (SAS)
AF:
AC:
19
AN:
1306
European-Finnish (FIN)
AF:
AC:
104
AN:
4118
Middle Eastern (MID)
AF:
AC:
1
AN:
80
European-Non Finnish (NFE)
AF:
AC:
471
AN:
22488
Other (OTH)
AF:
AC:
10
AN:
624
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.329
Heterozygous variant carriers
0
77
155
232
310
387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions as Germline
View on ClinVar Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.